The company's low P/S ratio may be due to its receding reven...
The company's low P/S ratio may be due to its receding revenue and the market's belief that the recent revenue performance isn't good enough to keep up with the industry. If recent medium-term revenue trends continue, it's hard to see the share price experience a reversal of fortunes anytime soon.
Hubei Goto Biopharm Co.,Ltd.'s (SZSE:300966) Share Price Boosted 31% But Its Business Prospects Need A Lift Too
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment